Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy.
| Image |  |
|---|---|
| Description | scientific article published on 26 January 2013 |
| Author/s |
author: Qiang Shen |
| Publication date | January 26, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |